Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Paying user area

Try for free

Regeneron Pharmaceuticals Inc. pages available for free this week:

• Common-Size Balance Sheet: Assets 
• Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
• Analysis of Profitability Ratios 
• Analysis of Solvency Ratios 
• Analysis of Short-term (Operating) Activity Ratios 
• Common Stock Valuation Ratios 
• Enterprise Value to EBITDA (EV/EBITDA) 
• Net Profit Margin since 2005 
• Operating Profit Margin since 2005 
• Total Asset Turnover since 2005 

The data is hidden behind: . Unhide it.

• Get full access to the entire website from $10.42/mo, or

• get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.

Get access

This is a one-time payment. There is no automatic renewal.

---

We accept:

Regeneron Pharmaceuticals Inc., common-size consolidated income statement (quarterly data)

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).